Drug Resistant Pathogens: Diagnosis, Treatment, and Global Health Implications
A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Bacterial Pathogens".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 420
Special Issue Editors
Interests: sepsis; critical illness; antimicrobial stewardship
Special Issues, Collections and Topics in MDPI journals
Interests: One Health; drug resistance; microbiome
Special Issues, Collections and Topics in MDPI journals
Interests: antibiotic; resistance; microbiology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
this Special Issue, "Drug Resistant Pathogens: Diagnosis, Treatment, and Global Health Implications", will highlight the pressing threat posed by drug-resistant microorganisms to global health. Antimicrobial abuse and misuse have led to an increase in drug resistance in bacteria, viruses, fungi, and parasites. This Special Issue will investigate novel treatment approaches to combating resistances, as well as diagnostics for the early and precise identification of resistant strains. This Special Issue will consider the intricacy of resistance mechanisms, including hereditary and environmental components, and their consequences for public health policy and therapeutic procedures. The socioeconomic cost of medication resistance will also be discussed, with an emphasis on how differences in healthcare infrastructure and resource availability can worsen the problem's effects worldwide. We must aim to maintain the effectiveness of current therapies and encourage the sustainable use of antibiotics globally by conducting interdisciplinary research.
Dr. Giuseppe Pipitone
Dr. Alberto Enrico Maraolo
Dr. Luigi Principe
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antibiotics
- multi-drug-resistant microorganisms
- difficult-to-treat infections
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
